Healthy adult volunteers
Conditions
Interventions
None listed
Sponsors
Morishita Jintan Co., Ltd.
Review team Dr. Mamiko Kohno, Health Care Product Department, Morishita Jintan Co., Ltd. Mr. Tadashi Kanaya, Health Care Product Department, Morishita Jintan Co., Ltd. Mr. Akifumi Nagatomo, Health Care Product Department, Morishita Jintan Co., Ltd. Ms. Kumiko Nakamura, Health Care Product Department, Morishita Jintan Co., Ltd. Mr. Tomohiko Yamashita, Health Care Product Department, Morishita Jintan Co., Ltd. Research collaborator Professor Hiroharu Kamioka, Faculty of Regional Environme
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (PICOS) Participant: Healthy adults. Minors, pregnant women, and lactating women will be excluded. Intervention: Ingestion of food containing more than 0.1 mg of rose hip-derived tiliroside. Comparison: Ingestion of food not containing rose hip-derived tiliroside. Outcome: BMI, Body fat (abdominal total fat area, abdominal subcutaneous fat area, abdominal visceral fat area) Study design: Randomized parallel-group controlled trials, randomized crossover trials, quasi randomized controlled trials, and non-randomized controlled trials will be included. Eligibility is not restricted by language. The scientific papers and reports which give us enough research details will be included.
Exclusion criteria
Exclusion criteria: The literature which does not meet the key inclusion criteria, proceedings, and unpublished studies will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body mass index (BMI) Body fat (abdominal total fat area, abdominal subcutaneous fat area, abdominal visceral fat area) | — |
Countries
Japan
Contacts
Public ContactAkifumi Nagatomo
Morishita Jintan Co., Ltd. Health Care Product Department
Outcome results
None listed